enterica serovar Typhimurium Species 0.000 description 2 235000014469 Bacillus subtilis Nutrition 0.000 description 2.238000011144 upstream manufacturing Methods 0.000 description 3.238000010369 molecular cloning Methods 0.000 description 3.229920001850 Nucleic acid sequence Polymers 0.000 description 3.SBUJHOSQTJFQJX-NOAMYHISSA-N Kanamycin Chemical compound SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4.241000193738 Bacillus anthracis Species 0.000 description 4.125000003729 nucleotide group Chemical group 0.000 description 5.BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl β-D-thiogalactopyranoside Chemical compound BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 5.238000004519 manufacturing process Methods 0.000 abstract description 8.230000001131 transforming Effects 0.000 claims description 2.239000002157 polynucleotide Substances 0.000 claims description 15.229920000023 polynucleotide Polymers 0.000 claims description 15.108090000623 proteins and genes Proteins 0.000 claims abstract description 43.102000004169 proteins and genes Human genes 0.000 claims abstract description 43.Publication of US20050153339A1 publication Critical patent/US20050153339A1/en Priority to US11/447,892 priority patent/US7405059B2/en Application granted granted Critical Publication of US7094573B2 publication Critical patent/US7094573B2/en Priority to US12/142,313 priority patent/US20080274503A1/en Status Expired - Fee Related legal-status Critical Current Anticipated expiration legal-status Critical Links ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US39143302P external-priority Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc Priority to US11/004,853 priority Critical patent/US7094573B2/en Assigned to HUMAN GENOME SCIENCES, INC. Original Assignee Human Genome Sciences Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) ( en Inventor Michael Laird Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Granted Application number US11/004,853 Other versions US7094573B2
Shine dalgarno sequence pdf#
Google Patents Modified shine-dalgarno sequences and methods of use thereofĭownload PDF Info Publication number US20050153339A1 US20050153339A1 US11/004,853 US485304A US2005153339A1 US 20050153339 A1 US20050153339 A1 US 20050153339A1 US 485304 A US485304 A US 485304A US 2005153339 A1 US2005153339 A1 US 2005153339A1 Authority US United States Prior art keywords sequence vector sequences shine seq Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US20050153339A1 - Modified shine-dalgarno sequences and methods of use thereof US20050153339A1 - Modified shine-dalgarno sequences and methods of use thereof
0 kommentar(er)
